Evaluation of an Early Support Programme in Orthophony

  • STATUS
    Recruiting
  • participants needed
    200
  • sponsor
    Centre Hospitalier Sud Francilien
Updated on 5 August 2020
premature birth
intrauterine growth retardation

Summary

Prospective, interventionnal with minimal risks and constraints, multicentric, non-randomized, open study, to measure the impact of an early support programme in speech and language therapy for vulnerable children (PAPEV-ortho), in children born very prematurely or very hypotrophically, on the incidence of language and communication deficits at the corrected age of 2 years.

Description

Prospective, interventionnal with minimal risks and constraints, multicentric, non-randomized, open study, to measure the impact of an early support programme in speech and language therapy for vulnerable children (PAPEV-ortho), in children born very prematurely or very hypotrophically, on the incidence of language and communication deficits at the corrected age of 2 years.

Parents of eligible children are informed of the study either during the hospitalization of the neonatal newborn by a hospital physician, or during a consultation performed during the first 6 months by a pilot physician from the RPSOF-ASNR network, hospital or private practitioner. Parents who agree that the data collected about their child may be used in the study sign a written declaration of free and informed consent.

The Early Support Programme in orthophony (PAPEV-ortho) is systematically proposed to families with possible access to a language therapist in the network.

Early support in speech therapy lasts between 6 months and 24 months of corrected age. It includes 10 to 20 sessions depending on the child's needs. These sessions are conducted by a speech-language pathologist from the RPSOF-ASNR network, trained in the issues specific to the very premature child and the network's tools. The support focuses on:

  • the development of parental sensitivity and receptivity
  • the development of parental reactivity
  • optimization of communication sequences in routine acts and play
  • the development of the child's intentionality in play and routine acts
  • support for verbal and non-verbal oral communication The participation of the child and his or her parents in the study ends at the end of the consultations and evaluations carried out at 24 months of corrected age.

Children within the group that followed the PAPEV-ortho program will be compared to children who did not benefit from this program.

Details
Condition Premature Birth, Developmental language disorder
Age 1years or below
Treatment Early Support Programme in Orthophony
Clinical Study IdentifierNCT04384328
SponsorCentre Hospitalier Sud Francilien
Last Modified on5 August 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Premature birth < 32 weeks of amenorrhea
or premature birth with intrauterine growth restriction (IUGR) < P3
corrected age 6 months at the time of inclusion
affiliation to a social security system + mutual insurance

Exclusion Criteria

genetic pathology
ongoing developmental care: psychomotricity or speech therapy
neuromuscular pathology affecting oral and facial motor skills
severe oral disorders: feeding by gastric tube or gastrostomy
severe sensory, auditory or visual impairment
neither of the 2 French-speaking parents
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.